5-benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate) is a potent and selective ligand for benzodiazepine (BZ) receptors. Biochemical investigations indicate that ZK 91296 may be a partial agonist at BZ receptors. Such partial agonism may explain to some extent why ZK 91296 needs higher BZ receptor occupancy than diazepam for the same effect against chemical convulsants and for behavioural effects. The lack of sedative effects, and the very potent inhibition of reflex epilepsy, spontaneous epilepsy and DMCM-induced seizures suggest, furthermore, that ZK 91296 may possess pharmacological selectivity for a particular type of BZ receptor interaction, perhaps including topographic as well as receptor subtype differentiation.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF00464788DOI Listing

Publication Analysis

Top Keywords

91296 partial
8
partial agonist
8
benzodiazepine receptors
8
0
4
agonist benzodiazepine
4
receptors 5-benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate
4
5-benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate potent
4
potent selective
4
selective ligand
4
ligand benzodiazepine
4

Similar Publications

Rationale: Although all of the benzodiazepines in use for the treatment of anxiety are presumably full agonists, it is conceivable that partial benzodiazepine agonists may also be clinically effective on the basis of their effects in preclinical models of anxiety.

Objectives: To compare the anxiolytic-like effects of different pharmacological/chemical classes of partial benzodiazepine agonists in the pigeon conflict procedure.

Methods: Anticonflict effects in pigeons whose responding was maintained under a multiple FR30 food:FR30 food+shock schedule were characterized by 1) the magnitude of punished responding or 2) the percentage of pigeons (n=5-7/dose) showing significant increases in punished responding.

View Article and Find Full Text PDF

Based on the structure of ZK91296 (4d), a high affinity partial agonist of the central benzodiazepine (omega) receptor, a series of pyrrolo[2,3-c]pyridine-5-carboxylate derivatives having mainly aralkyl and aralkyloxy substituents at C-3 was synthesized. The in vitro binding affinities of these compounds for three subclasses of the omega receptor (omega1, omega2, omega5) were determined using rat brain tissue. Practically all of these compounds (except the diethyl ester derivative 22c) showed an approximately twofold selectivity for omega1 (IC50's in the 200-500 nM range) compared to omega2 receptors and practically no affinity for omega5 receptors.

View Article and Find Full Text PDF

Benzodiazepine (omega) receptor partial agonists and the acquisition of conditioned fear in mice.

Psychopharmacology (Berl)

September 1995

Synthélabo Recherche, Bagneux, France.

It is well established that benzodiazepines can produce anterograde amnesia in humans and interfere with the acquisition of passive avoidance and spatial responses in rodents. However, the extent to which the disruption of learning is a secondary effect of the sedation produced by these drugs has not been clearly established. In order to investigate this question, the effects of several BZ (omega) receptor partial agonists were studied on the acquisition of conditioned fear (passive avoidance learning) in mice.

View Article and Find Full Text PDF

Partial and full agonists/inverse agonists affect [35S]TBPS binding at different occupancies of central benzodiazepine receptors.

Eur J Pharmacol

August 1993

Department of Molecular Pharmacology, Hungarian Academy of Sciences, Budapest.

Concentration-dependent effects of benzodiazepine receptor ligands were examined on nonequilibrium binding of t-butylbicyclophosphoro[35S]thionate (TBPS, 20 min of incubation at 25 degrees C) to synaptosomal membranes of rat cerebral cortex. Benzodiazepine receptor occupancies were calculated from the displacing potencies of the ligands determined for [3H]flumazenil binding under identical conditions. Greater maximal enhancing (i.

View Article and Find Full Text PDF

Pharmacokinetics of two partial benzodiazepine receptor agonistic beta-carboline derivatives in healthy volunteers.

Arzneimittelforschung

May 1993

Research Laboratories, Schering Aktiengesellschaft, Berlin (Fed. Rep. of Germany.

Plasma levels of the two beta-carboline derivatives, ZK 91,296 (ethyl 5-benzyloxy-4-methoxymethyl-9H-pyrido (3,4-b) indole-3-carboxylate, CAS 83910-34-3) and ZK 95,962 (ethyl 5-isopropoxy-4-methoxymethyl-9H-pyrido (3,4-b) indole-3-carboxylate, CAS 101071-43-6) were measured in a total of 46 healthy male volunteers. The doses ranged from 1 to 40 micrograms/kg injected intravenously and from 40 to 600 mg given orally. Following i.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!